Leonardo Drs, Inc. · NASDAQ:DRS
Leonardo Drs — Q2 2026 Earnings Presentation
8 slides from Leonardo Drs's earnings presentation, Jul 30, 2026
Slide 1: Quarterly Earnings Presentation Q2 | 2026
Quarterly Earnings Presentation Q2 | 2026 July 30, 2026
Slide 2: Disclaimers
Disclaimers Forward-Looking Statements In this presentation, when using the terms the “company,” “DRS,” “we,” “us” and “our,” unless otherwise indicated or the context otherwise requires, we are referring to Leonardo DRS, Inc. This presentation contains forward-looking statements and cautionary stat
Slide 3: Key Messages
Key Messages Excellent second quarter with steady execution driving double-digit growth and significant margin expansion • Q2 organic revenue growth of 10% year-over-year, reinforces the strength of the company’s differentiated portfolio and strategy 1 • Adjusted EBITDA growth of 33% and margin expa
Slide 4: Q2 2026 Leonardo DRS Results Summary
Q2 2026 Leonardo DRS Results Summary Revenue Adjusted EBITDA * Adjusted Net Earnings * (Dollars in millions) (Dollars in millions) (Dollars in millions) $913 $128 $94 $829 ▲ 10% ▲ 33% $96 ▲ 52% $62 Revenue growth was led by Adjusted EBITDA growth Increased operational programs related to tactical wa
Slide 5: Q2 2026 Segment Results Summary
Q2 2026 Segment Results Summary Revenue Segment Adjusted EBITDA * Segment Adjusted EBITDA Margin * (Dollars in millions) (Dollars in millions) Advanced Sensing and Computing (ASC) $587 11.8% $542 $69 10.7% ▲ 8% ▲ 110 bps $58 ▲ 19% Adjusted EBITDA growth stemmed from better Increased margin resulted
Slide 6: Increasing 2026 Adjusted EBITDA and Adjusted Diluted EPS Guidance
Increasing 2026 Adjusted EBITDA and Adjusted Diluted EPS Guidance Delivering Healthy Organic Revenue and Adjusted EBITDA Margin Expansion • Robust first half performance coupled with growing funded (In millions, except per share amounts) backlog offers solid visibility into the revenue range Revenue
Slide 7: Non-GAAP Financial Measures
Non-GAAP Financial Measures Definitions and Reconciliations (Dollars in millions) Three Months Ended June 30, In addition to the results reported in accordance with U.S. GAAP included throughout this 2025 2026 presentation, the company has provided information regarding “Adjusted EBITDA,” “Adjusted
Slide 8: Non-GAAP Financial Measures (Continued)
Non-GAAP Financial Measures (Continued) Definitions and Reconciliations (In millions, except per share amounts) Three Months Ended June 30, Adjusted Net Earnings and Adjusted Diluted EPS are defined as net earnings 2025 2026 excluding amortization of acquired intangible assets, deal-related transact